| Pharmaceutical active ingredients: |
| Enalapril Maleate |
| Available forms, composition and doses of Xanef Cor: |
| Tablets; Oral; Enalapril Maleate 2.5 mg |
| Xanef Cor medical category: |
| Human:ACE inhibitorsAngiotensin-Converting Enzyme inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09AA02 - Enalapril |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vorizol | Voriconazole | Merck |
| Vytorin | Ezetimibe; Simvastatin | Merck; DKSH; Four Star; MSP Singapore; Schering-Plough; Zuellig Pharma |
| Warfilone | Warfarin Sodium | Merck |
| Winter AP | Dexbrompheniramine Maleate; Pseudoephedrine Sulfate | Merck |
| Xanef | Enalapril Maleate; Enalaprilat | Merck |
| Zacnan | Minocycline Hydrochloride | Merck |
| Zemuron | Rocuronium Bromide | Merck; Bayer Schering Pharma; Organon; Schering-Plough |
| Zenhale | Formoterol Fumarate Dihydrate; Mometasone Furoate | Merck |
| Zetia | Ezetimibe | Merck; MSP Singapore; Schering-Plough |
| Ziac | Bisoprolol Fumarate; Hydrochlorothiazide | Merck; Barr Laboratories; Duramed Pharmaceuticals; Serono; Zuellig Pharma |